Edition:
United States

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

7.71USD
17 Aug 2018
Change (% chg)

$-0.20 (-2.53%)
Prev Close
$7.91
Open
$7.87
Day's High
$7.87
Day's Low
$7.53
Volume
47,008
Avg. Vol
34,020
52-wk High
$38.68
52-wk Low
$6.99

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 10.14 -0.365
Mar '18 0.50 -0.720
FY 2017 Dec '17 2.78 -0.087
Sep '17 0.91 -0.373
Jun '17
Mar '17 0.45 -1.079
FY 2016 Dec '16 0.45 -0.221
Sep '16 0.22 -0.155
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.22 0.50 0.00 --
Quarter Ending Dec-18 4 0.38 1.00 0.00 --
Year Ending Dec-18 4 11.22 12.04 10.60 --
Year Ending Dec-19 4 0.50 1.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 4 -0.87 -0.79 -0.95 --
Quarter Ending Dec-18 4 -0.93 -0.89 -0.96 --
Year Ending Dec-18 4 -2.88 -2.76 -2.99 --
Year Ending Dec-19 4 -3.70 -3.31 -4.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.69 32.76
P/E High - Last 5 Yrs. -- 300.66 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.99 5.75
Price to Book (MRQ) -- 15.52 5.00
Price to Tangible Book (MRQ) -- 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.56 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.51 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.85 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) -- 5.46 3.03
LT Debt to Equity (MRQ) -- 35.26 12.51
Total Debt to Equity (MRQ) -- 37.08 16.85
Interest Coverage (TTM) -- -102.36 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.69 10.68
Operating Margin (TTM) -- -759.79 4.32
Operating Margin - 5 Yr. Avg. -- -621.72 6.11
Pre-Tax Margin (TTM) -- -733.64 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.42 6.51
Net Profit Margin (TTM) -- -735.01 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.47 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,231,105 860,375,625
Net Income/Employee (TTM) -- 3,144,294 101,207,245
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -- 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -- 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39

Performance for Menlo Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 53
13 Week -- -- -- 66
26 Week -- -- -- 80
52 Week -- -- -- 50
YTD -- -- -- 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.21%
# of Holders: 79
Total Shares Held: 17,512,006
3 Mo. Net Change: 454,070
# New Positions: 23
# Closed Positions: 14
# Increased Positions: 49
# Reduced Positions: 27
# Net Buyers: 22
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.